Myrehaug Sten, Sahgal Arjun, Hayashi Motohiro, Levivier Marc, Ma Lijun, Martinez Roberto, Paddick Ian, Régis Jean, Ryu Samuel, Slotman Ben, De Salles Antonio
Department of Radiation Oncology, University of Toronto, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada.
Department of Neurosurgery, Tokyo Women's Medical University, Tokyo, Japan.
J Neurosurg Spine. 2017 Oct;27(4):428-435. doi: 10.3171/2017.2.SPINE16976. Epub 2017 Jul 14.
OBJECTIVE Spinal metastases that recur after conventional palliative radiotherapy have historically been difficult to manage due to concerns of spinal cord toxicity in the retreatment setting. Spine stereotactic body radiation therapy (SBRT), also known as stereotactic radiosurgery, is emerging as an effective and safe means of delivering ablative doses to these recurrent tumors. The authors performed a systematic review of the literature to determine the clinical efficacy and safety of spine SBRT specific to previously irradiated spinal metastases. METHODS A systematic literature review was conducted, which was specific to SBRT to the spine, using MEDLINE, Embase, Cochrane Evidence-Based Medicine Database, National Guideline Clearinghouse, and CMA Infobase, with further bibliographic review of appropriate articles. Research questions included: 1) Is retreatment spine SBRT efficacious with respect to local control and symptom control? 2) Is retreatment spine SBRT safe? RESULTS The initial literature search retrieved 2263 articles. Of these articles, 160 were potentially relevant, 105 were selected for in-depth review, and 9 studies met all inclusion criteria for analysis. All studies were single-institution series, including 4 retrospective, 3 retrospective series of prospective databases, 1 prospective, and 1 Phase I/II prospective study (low- or very low-quality data). The results indicated that spine SBRT is effective, with a median 1-year local control rate of 76% (range 66%-90%). Improvement in patients' pain scores post-SBRT ranged from 65% to 81%. Treatment delivery was safe, with crude rates of vertebral body fracture of 12% (range 0%-22%) and radiation-induced myelopathy of 1.2%. CONCLUSIONS This systematic literature review suggests that SBRT to previously irradiated spinal metastases is safe and effective with respect to both local control and pain relief. Although the evidence is limited to low-quality data, SBRT can be a recommended treatment option for reirradiation.
目的 传统姑息性放疗后复发的脊柱转移瘤,由于再次治疗时担心脊髓毒性,一直以来难以处理。脊柱立体定向体部放射治疗(SBRT),也称为立体定向放射外科,正逐渐成为向这些复发性肿瘤给予消融剂量的一种有效且安全的方法。作者对文献进行了系统综述,以确定针对先前接受过放疗的脊柱转移瘤的脊柱SBRT的临床疗效和安全性。方法 进行了一项针对脊柱SBRT的系统文献综述,使用MEDLINE、Embase、Cochrane循证医学数据库、国家指南库和CMA信息库,并对相关文章进行进一步的文献回顾。研究问题包括:1)再次治疗的脊柱SBRT在局部控制和症状控制方面是否有效?2)再次治疗的脊柱SBRT是否安全?结果 初步文献检索获得2263篇文章。其中,160篇可能相关,105篇被选作深入综述,9项研究符合所有纳入分析的标准。所有研究均为单机构系列研究,包括4项回顾性研究、3项前瞻性数据库的回顾性系列研究、1项前瞻性研究和1项I/II期前瞻性研究(数据质量低或极低)。结果表明,脊柱SBRT是有效的,1年局部控制率中位数为76%(范围66%-90%)。SBRT后患者疼痛评分的改善范围为65%至81%。治疗实施是安全的,椎体骨折的粗发生率为12%(范围0%-22%),放射性脊髓病的发生率为1.2%。结论 这项系统文献综述表明,对先前接受过放疗的脊柱转移瘤进行SBRT在局部控制和缓解疼痛方面是安全有效的。尽管证据限于低质量数据,但SBRT可作为再照射的推荐治疗选择。